After four bouts with cancer and a bone marrow transplant, Josh Hardy’s life was threatened by a virus. After exhausting other options, his doctors at St. Jude Children’s Research Hospital believed he needed an experimental drug to get better. Their requests to the maker of the drug had been denied.

I got to be the person who told Josh’s mom her son would indeed receive the life-saving treatment. While the family mounted a social media campaign, #saveJosh, the drug manufacturer quietly worked out a deal with federal officials to enroll Josh into a new clinical trial.

I pitched this story and our booker, Katy Conrad, lined up the interview with Josh’s mom. While I was enroute to the interview, producers at “CBS Evening News” secured an interview with the drug maker’s CEO. By then he was in a position to reveal the new trial.

Josh was well enough to return to his home in Virginia a few months after receiving treatment. Sadly, he passed away in 2016.